Company intelligence / Profile preview
Grand Pharmaceutical Group
Wuhan, Hubei, China
- Ownership
- Public · 00512.HK
- Employees
- ~10000
- Development stage
- Other
01
Overview
Grand Pharmaceutical has multiple commercial drug products (over 200 listed in China's National Reimbursement Drug List, with 16 exceeding $100M in value), including innovative drugs, generics, and medical devices. Its innovative programs include mRNA-based therapies in Phase 1-3, and globally-approved products in oncology and ophthalmology (such as SIR-Spheres Y-90 and OC-01 nasal spray for dry eye). Recent approvals include the FDA approval for new indications of SIR-Spheres® Y-90 and China's approval for OC-01.[1][4]
- Therapeutic areas
- Critical CareOphthalmologyInfectious DiseasesOncologyOtherPulmonologyCardiovascular
- Modalities
- Small moleculeBiologicmRNA-based drugsMedical deviceRadiopharmaceuticalRecombinant proteinGene therapy
- Industry
- Pharma
02
Drug pipeline
17 assets16 more assets in the full pipeline.
Request access →03
Partnerships
eTheRNA (mRNA collaboration in China)[4]Multiple university R&D collaborations globally[3]Numerous regional distributors (30+)[2]
Beyond the preview
Go deeper on Grand Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grand Pharmaceutical Group.